Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension

Abstract

Fermented milk (FM) with putative antihypertensive effect in humans could be an easy applicable lifestyle intervention against hypertension. The mode of action is supposed to be through active milk peptides, shown to possess in vitro ACE-inhibitory effect. Blood pressure (BP) reductions upto 23 mm Hg have been reported in spontaneously hypertensive rats fed FM. Results from human studies of the antihypertensive effect are inconsistent. However, many studies suffer from methodological weaknesses, as insufficient blinding and the use of office BP measurements. We conducted a randomised, double-blind placebo-controlled study of the antihypertensive effect of Lactobacillus helveticus FM in 94 prehypertensive and borderline hypertensive subjects. The participants were randomised into three treatment groups with a daily intake of 150 ml of FM, 300 ml of FM or placebo (chemically acidified milk). The primary outcome was repeated 24-h ambulatory BP measurements. There were no statistically significant differences in the outcome between the groups (systolic BP (SBP), P=0.9; diastolic BP (DBP), P=0.2). However, the group receiving 300 ml FM had reduced BP across the 8-week period in several readings, which could be compatible with a minor antihypertensive effect. Heart rate and lipids remained unchanged between groups. Hence, our study does not support earlier studies measuring office BP-measurements, reporting antihypertensive effect of FM. Based on straight performed 24-h ambulatory BP measurements, milk fermented with Lactobacillus helveticus does not posses significant antihypertensive effect.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17 (2): 151–183.

  2. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21 (6): 1011–1053.

  3. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006; 24 (2): 215–233.

    Article  CAS  Google Scholar 

  4. Massey LK . Dairy food consumption, blood pressure and stroke. J Nutr 2001; 131 (7): 1875–1878.

    Article  CAS  Google Scholar 

  5. Abbott RD, Curb JD, Rodriguez BL, Sharp DS, Burchfiel CM, Yano K . Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke 1996; 27 (5): 813–818.

    Article  CAS  Google Scholar 

  6. Barr SI, McCarron DA, Heaney RP, wson-Hughes B, Berga SL, Stern JS et al. Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 2000; 100 (7): 810–817.

    Article  CAS  Google Scholar 

  7. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM . Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005; 28 (12): 2926–2932.

    Article  CAS  Google Scholar 

  8. FitzGerald RJ, Murray BA, Walsh DJ . Hypotensive peptides from milk proteins. J Nutr 2004; 134 (4): 980S–988S.

    Article  CAS  Google Scholar 

  9. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen ML . Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol 2001; 52 (4 Part 2): 745–754.

    CAS  PubMed  Google Scholar 

  10. Takano T . Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie Van Leeuwenhoek 2002; 82 (1–4): 333–340.

    Article  CAS  Google Scholar 

  11. Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppala A, Piilola K, Korpela R et al. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 2000; 66 (16): 1535–1543.

    Article  CAS  Google Scholar 

  12. Hayakawa K, Kimura M, Kamata K . Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 2002; 438 (1–2): 107–113.

    Article  CAS  Google Scholar 

  13. Van de Water J . Yogurt and immunity: the benefits of fermented milk products that contain lactic acid bacteria. In: Farquhar WB, (ed). Handbook of Fermented Food. CRC Press: Boca Raton, FL, 2003 pp 113–144.

    Chapter  Google Scholar 

  14. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y . Effect of powdered fermented milk with lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005; 24 (4): 257–265.

    Article  Google Scholar 

  15. Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM . Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension 2008; 51 (2): 399–405.

    Article  CAS  Google Scholar 

  16. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 2003; 57 (3): 490–495.

    Article  CAS  Google Scholar 

  17. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R . Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005; 18 (12 Part 1): 1600–1605.

    Article  Google Scholar 

  18. Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A . Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 2000; 83 (2): 255–263.

    Article  CAS  Google Scholar 

  19. Seppo L, Jauhiainen T, Poussa T, Korpela R . A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003; 77 (2): 326–330.

    Article  CAS  Google Scholar 

  20. Lee YM, Skurk T, Hennig M, Hauner H . Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 2007; 46 (1): 21–27.

    Article  CAS  Google Scholar 

  21. Campo IS, Beghin JC . Dairy food consumption, production, and policy in Japan. Working Paper 05–WP 401. 1–8–2005.

  22. van Mierlo LA, Koning MM, van der ZK, Draijer R . Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr 2009; 89 (2): 617–623.

    Article  CAS  Google Scholar 

  23. Xu JY, Qin LQ, Wang PY, Li W, Chang C . Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008; 24 (10): 933–940.

    Article  CAS  Google Scholar 

  24. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 2005; 94 (1): 84–91.

    Article  CAS  Google Scholar 

  25. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A . Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000; 54 (4): 288–297.

    Article  CAS  Google Scholar 

  26. Usinger L, Ibsen H, Jensen LT . Does fermented milk possess antihypertensive effect in humans? J Hypertens 2009; 27 (6): 1115–1120.

    Article  CAS  Google Scholar 

  27. Foltz M, Meynen EE, Bianco V, van PC, Koning TM, Kloek J . Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 2007; 137 (4): 953–958.

    Article  CAS  Google Scholar 

  28. Wuerzner G, Peyrard S, Blanchard A, Lalanne F, Azizi M . The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N- or C-terminal angiotensin converting enzyme active sites in humans. J Hypertens 2009; 27 (7): 1404–1409.

    Article  CAS  Google Scholar 

  29. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903–1913.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Usinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Usinger, L., Jensen, L., Flambard, B. et al. The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension. J Hum Hypertens 24, 678–683 (2010). https://doi.org/10.1038/jhh.2010.4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2010.4

Keywords

This article is cited by

Search

Quick links